Dear Valued Subscriber,   Ladies and gentleman we don’t need to tell you what kind of day NSRS had today. After trading over 16.5 Million shares we’re pretty sure everyone in the market saw this shining star hit a new 52 week high today! NSRS hit $0.97 today which...

  Today's pick is: NSRS Dear Valued Subscriber,   NSRS has come out of the gates on fire yet again already showing investors potential gains of almost 10%! We’ve said it before, and we’ll say it again, this is becoming a daily occurrence for NSRS. Wouldn’t you like...

  Today's pick is: NSRS Dear Valued Subscribers,   NSRS has come out of the gates on fire yet again already showing investors potential gains of almost 10%! We’ve said it before, and we’ll say it again, this is becoming a daily occurrence for NSRS. Wouldn’t you like the...

  Today's pick is: NSRS Dear Valued Subscriber,   NSRS has come out of the gates on fire yet again already showing investors potential gains of almost 10%! We’ve said it before, and we’ll say it again, this is becoming a daily occurrence for NSRS. Wouldn’t you like...

  Dear Valued Subscriber,   NSRS has come out of the gates on fire yet again already showing investors potential gains of almost 10%! We’ve said it before, and we’ll say it again, this is becoming a daily occurrence for NSRS. Wouldn’t you like the opportunity to see...

  News Alert on VRAL:       SAN MARINO, Calif.--(BUSINESS WIRE)-- Viral Genetics, Inc. (Pink Sheets: VRAL) today posted to its website a President’s Letter to Shareholders that reviews the past year and looks ahead to what 2012 holds for the Company. Highlights of the President’s letter, including key updates on the Company’s important cancer study and biofuel testing...